Overview

Effect of Anti-Inflammatory Agents on Biological Responses to Endotoxin Inhalation in Healthy Subjects

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to characterize the biological responses elicited by endotoxin inhalation applied to healthy subjects, and to assess the effect of standard anti-inflammatory agents (i.e. adalimumab and methylprednisolone) on these biological responses.
Phase:
Early Phase 1
Details
Lead Sponsor:
Brugmann University Hospital
Treatments:
Adalimumab
Anti-Inflammatory Agents
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate